ChartMill assigns a fundamental rating of 2 / 10 to TTPH.
ChartMill assigns a valuation rating of 3 / 10 to Tetraphase Pharmaceu (TTPH). This can be considered as Overvalued.
Tetraphase Pharmaceu (TTPH) has a profitability rating of 1 / 10.
The dividend rating of Tetraphase Pharmaceu (TTPH) is 0 / 10 and the dividend payout ratio is 0%.